The healthcare landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this approach offers a more convenient way to deliver GLP-1 drugs. These transdermal systems slowly release the drug through the skin offering a stable level of the therapeutic agent, wh… Read More